Table 2 Demographic information of Barrett’s oesophagus patients selected for this study.

From: Infectious agents and progression from Barrett’s oesophagus to oesophageal adenocarcinoma: a nested case-control study

 

Non-progressors N (%)

Progressors N (%)

Total

298

150

Age at Barrett’s diagnosis (years)

 <50

40 (13.4)

20 (13.3)

 50– < 60

74 (24.8)

37 (24.7)

 60– < 70

100 (33.6)

49 (32.7)

 70– < 80

67 (22.5)

35 (23.3)

 80+

17 (5.7)

9 (6.0)

Sex

 Women

85 (28.5)

44 (29.3)

 Men

213 (71.5)

106 (70.7)

Healthcare Trust

 Belfast

181 (60.7)

91 (60.7)

 North

48 (16.1)

29 (19.3)

 South

26 (8.7)

11 (7.3)

 West

43 (14.4)

19 (12.7)

Specialised intestinal metaplasia

 No/unknown

62 (20.8)

32 (21.3)

 Yes

236 (79.2)

118 (78.7)

Barrett’s diagnosis year

 1993–1995

67 (22.5)

28 (18.7)

 1996–2000

104 (34.9)

52 (34.7)

 2001–2005

102 (34.2)

52 (34.7)

 2006–2010

25 (8.4)

18 (12.0)